MSc in Advanced Oncology Nursing
PhD (c)
EONS' Communication Working Group Member/Young Cancer Nurse Representative of CY
Head Nurse at German Oncology Center
Induction-concurrent chemotherapy does not significantly improve progression-free survival compared with concurrent-adjuvant chemotherapy in high-risk N2–3 nasopharyngeal carcinoma. https://t.co/hLrK38j3Cx
The value of therapy isn’t just life extension; it must also consider quality of life, financial toxicity, and accessibility. Read Dario @darioT_’s column on #ESMODailyReporter about the importance of a value-based approach to #OncologyInnovation.
📌https://t.co/mDVeIuODCF
Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era out on JAMA internal Medicine
https://t.co/22j701xG3a
This cohort study examined overtreatment trends for men with limited life expectancy (LE) and clinically localized #ProstateCancer in the Veterans Affairs health system from 2000 to 2019. It found that overtreatment, despite increased use of active surveillance, persists for men with intermediate- and high-risk prostate cancer, particularly through the use of radiotherapy. For men with LE less than 10 years, definitive treatment for low-risk disease declined, while treatment for intermediate-risk disease increased, primarily with radiotherapy. Similarly, for men with LE less than 5 years, the use of radiotherapy for high-risk disease significantly rose over the study period, highlighting continued overtreatment in this population.
@TimDaskivich@johnleppert
Ping @nataliagandur@bavilima@yekeduz_emre
Congrats to @CZamboglou and @Str_onc from @goc_cy for their first patient enrollment in the prospective HypoPro/HypoElect Phase II trials, using #ArteraAI MMAI to risk stratify patients with high-risk #prostatecancer and deliver precise treatments.
Fantastic to be at Agora 3.0 and showcasing the project at #ResearchersNight in Nicosia today. Thank you @silversky3D for support and showcasing your innovative work - soon a new output will be developed together with @mavraamides
Get more insights on our activities, from the partners leading them, with our video interview series!
Here's Zheshen Jiang from Centre Hospitalier Universitaire De Liège (Belgium), on coordinating the clinical partners and the studies being conducted 👇
https://t.co/bqqOCziBqG
Support, empower and offer free and evidence-based information to your patients!!
Mr David Somekh, Center for Empowering Patients and Communities
@dioptra_project@goc_cy@CZamboglou
Vaccines can play a crucial role in preventing certain cancers and our @SilviaRomeo_8 shared her views today! Our recommendations:
1️⃣ Boost vaccination across Europe🌐
2️⃣ EU-wide monitoring system 📊
3️⃣ Target high-risk groups. 📑
Read our Manifesto 🔗 https://t.co/KU5eZUqRL9
I highly recommend this workshop having been lucky to participate in the 1st where I found a fab cancer nursing research tribe. The doc journey can be lonely & this was a nugget of support. Apply for 5th EONS PhD Research Workshop 2024-Ghent https://t.co/YpS8l8qBjB
Do not forget to attend the session "The next generation of Cancer Leaders" at 16:30, today!!
@demetrios_gr is presenting "Mapping existing digital skills training in oncology across Europe" which is a part of TRANSiTION Project.@EuropeanCancer@AndreasC466@Lygia65922356
What we learn becomes part of who we are!!!
Grab the opportunity to participate at #EONS17 @ESMO2024 to learn more about cancer care from the experts. @MSDCyprus @helitropen @demetrios_gr @druryal @Jdmunter1 @AndreasC466 @mattfowler751